2m 2m 2m 2m 2m 2m 2m
Guided Therapeut (GTHP)
OTC
$0.25+$0.05 (+25.00%)
Price as of Sep 09, 2026- $24.1MMarket Cap
- -13.79%1-Year Change
- Medical DevicesIndustry
Guided Therapeut (GTHP)
$0.25+$0.05 (+25.00%)
GTHP | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $0.25 | ||
Change | +$0.05 (+25.00%) | ||
Open | $0.20 | ||
High | $0.25 | ||
Low | $0.18 | ||
Previous Close | $0.20 | ||
Volume | 45,439 | ||
30-Day Average Volume | 14,631 | ||
1-Week Change | 0.00% | ||
1-Month Change | -13.79% | ||
1-Year Change | -13.79% | ||
3-Year Change | 76.60% | ||
5-Year Change | N/A | ||
Fundamentals | |||
Shares Outstanding | 96.5M | ||
Total Assets | $1.2M | ||
Market Cap | $24.1M | ||
Enterprise Value | $24.5M | ||
Period: QTR TTM FY | |||
Revenue | $0.00 | ||
Net Income | -$605,000.00 | ||
Free Cash Flow | -$319,000.00 | ||
EBIT | -$469,000.00 | ||
EBITDA | -$467,000.00 | ||
Net Working Capital | -$5.6M | ||
EPS | -$0.01 | ||
Enterprise Value/EBITDA | -52 | ||
Enterprise Value/Revenue | N/A | ||
P/B | -4 | ||
P/E | -25 | ||
PEG | N/A | ||
Price/Free Cash Flow | -76 | ||
Price/Operating Cash Flow | -76 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 800 | ||
Last Split Date | 03/29/2019 | ||
Earnings & Revenue